OCGN Ocugen, Inc.

0.9774USD-2.26%Mkt Cap: 331.45M $P/E: —

Ocugen, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients' health. The company's pipeline product inclu…

Key Statistics

Company
Market Cap331.45M USD
Enterprise Value319.38M USD
Revenue (TTM)4.58M USD
Gross Profit-39.18M USD
Net Income (TTM)-67.85M USD
Revenue/Share0.01 USD
Last Price0.9774 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees116
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.86
PEG—
EV/EBITDA-4.75
EV/Revenue69.72
P/S72.35
P/B-19.95
EPS (TTM)-0.26
EPS (Forward)-0.25
52W Range
0.96011% of range2.725
52W High2.725 USD
52W Low0.9601 USD
Profitability
Gross Margin0.00%
Oper. Margin-1105.11%
EBITDA Margin0.00%
Profit Margin-1537.41%
ROE557.67%
ROA-155.91%
Growth
Revenue Growth8.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-56.96M USD
CapEx (TTM)185.00K USD
FCF Margin-43.10%
FCF Yield-0.60%
Net Debt-12.06M USD
Net Debt/EBITDA0.18
Balance Sheet
Debt/Equity-2.72
Current Ratio0.80
Quick Ratio0.75
Book Value/Sh-0.05 USD
Cash/Share0.29 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateSep 30, 2019
Splits
Last Split1:60
Split DateSep 30, 2019
Analyst Consensus
Rating1.2 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)12.17 USD
Upside (mean)+1144.8%
Target Range8.000 USD – 22.00 USD
8.000+1144.8% to mean22.00
# Analysts6
Ownership
Shares Out.339.11M
Float333.78M
Insiders1.54%
Institutions43.41%
Short Interest
Short Ratio15.8d
Short % Float31.28%
Short % Out.31.28%
Shares Short106.06M
Short (prev mo.)101.77M
Technical
SMA 501.201 (-18.6%)
SMA 2001.486 (-34.2%)
Beta2.27
S&P 52W Chg15.84%
Avg Vol (30d)7.40M
Avg Vol (10d)6.49M
Technical Indicators
RSI (14)37.0
MACD-0.0621
MACD Signal-0.0677
MACD Hist.+0.0056
BB Upper1.083 USD
BB Middle1.027 USD
BB Lower0.9714 USD
BB Width10.85%
ATR (14)0.0686 USD
Vol Ratio (20d)1.32x